INS and Alzheimer disease: Interestingly, that approach is not at odds with the hypothesis suggested in the present article, because the brain cell-types with changed functions that determine AD are astrocytes, oligodendrocytes, neurons, endothelial cells, and microglia; as shown above, insulin and edaravone also benefit all of those brain cell-types.